Paediatric Diseases Working Party (PDWP)
Type of transplant:
Deadline for data collection:
To report the outcomes of adult SCD patients undergoing allo-HSCT from an HLA-identical, related donor or haploidentical and unrelated donors, with the main end point being the successful engraftment and overall survival, disease free survival at a certain point in time.
Key inclusion criteria:
All consecutive SCD patients older than 17 years who underwent allo-HSCT between Jan 2010 and June 2020, regardless of conditioning will be included.
Principal investigator email:
EBMT Study coordinator:
Study coordinator email: